SLC6A20 and neoplasm: Since SLC6A20 gene was the only geneindependently identified in these two studies for COVID-19 risk, wehave focused on SLC6A20 in human tumor samples toinvestigate SLC6A20 expression in human pan-cancersamples and its association with SARS-CoV-2-related genes and immuneinfiltration.